TRX818 | B1223

TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures.

TRX818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities. TRX-818, upon oral administration appears to induce cancer cell apoptosis and inhibits cancer cell proliferation. TRX818 also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures.

B1223 | TRX818 DataSheet

Alternate Name/Synonyms: Sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate

Appearance: Crystalline solid

Formulation: N/A

CAS Number: 1256037-58-7

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₆H₁₁FNNaO₅P

Molecular Weight: 393.21

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: An orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities

MDL Number: N/A

PubChem CID: N/A

SMILES: O=C1C=C(C2=CC=CC(F)=C2)NC3=C1C(P([O-])([O-])=O)=C(OC)C=C3.[Na+].[Na+]

InChi: InChI=1S/C16H13FNO5P.2Na/c1-23-14-6-5-11-15(16(14)24(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9;;/h2-8H,1H3,(H,18,19)(H2,20,21,22);;/q;2*+1/p-2

InChi Key: ZRPWVAHVWBPHID-UHFFFAOYSA-L